Lynn R. Webster

10.2k total citations · 2 hit papers
237 papers, 7.3k citations indexed

About

Lynn R. Webster is a scholar working on Anesthesiology and Pain Medicine, Public Health, Environmental and Occupational Health and Physiology. According to data from OpenAlex, Lynn R. Webster has authored 237 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Anesthesiology and Pain Medicine, 98 papers in Public Health, Environmental and Occupational Health and 58 papers in Physiology. Recurrent topics in Lynn R. Webster's work include Pain Management and Opioid Use (98 papers), Opioid Use Disorder Treatment (98 papers) and Pain Mechanisms and Treatments (45 papers). Lynn R. Webster is often cited by papers focused on Pain Management and Opioid Use (98 papers), Opioid Use Disorder Treatment (98 papers) and Pain Mechanisms and Treatments (45 papers). Lynn R. Webster collaborates with scholars based in United States, Belgium and United Kingdom. Lynn R. Webster's co-authors include Perry G. Fine, Jaakko Lappalainen, Mark Sostek, William D. Chey, Jan Tack, Brydon J. B. Grant, Himanshu Desai, Jeffrey Tobias, Michael Camilleri and Richard Rauck and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Lynn R. Webster

234 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool

2005 734 citations Lynn R. Webster et al. Pain Medicine profile →
Risk Factors for Opioid-Use Disorder and Overdose

2017 344 citations Lynn R. Webster profile →

Peers

Countries citing papers authored by Lynn R. Webster

Since Specialization

Citations

This map shows the geographic impact of Lynn R. Webster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynn R. Webster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynn R. Webster more than expected).

Fields of papers citing papers by Lynn R. Webster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynn R. Webster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynn R. Webster. The network helps show where Lynn R. Webster may publish in the future.

Co-authorship network of co-authors of Lynn R. Webster

This figure shows the co-authorship network connecting the top 25 collaborators of Lynn R. Webster. A scholar is included among the top collaborators of Lynn R. Webster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lynn R. Webster. Lynn R. Webster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effects of virtual reality neuroscience-based therapy on clinical and neuroimaging outcomes in patients with chronic back pain: a randomized clinical trial 2024 ·Pain ·Marta Čeko, (unknown), Lynn R. Webster, Tor D. Wager, Mark A. Lumley	10
2	Reversal of Opioid‐Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone 2024 ·The Journal of Clinical Pharmacology ·(unknown), (unknown), Lynn R. Webster, Phil Skolnick	9
3	Establishing Minimal Clinically Important Differences in Quality of Life Measures in Opioid-Induced Constipation 2021 ·Clinical Gastroenterology and Hepatology ·Jan Tack, Michael Camilleri, M. Hale, Bart Morlion, Srinivas Nalamachu, Lynn R. Webster, James Wild	9
4	Ventilatory Response to Hypercapnia as Experimental Model to Study Effectsof Oxycodone on Respiratory Depression 2021 ·PubMed ·Lynn R. Webster, (unknown), Gregory J. Stoddard, (unknown), (unknown), (unknown)	4
5	Naldemedine Improves Patient-Reported Outcomes of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain in the COMPOSE Phase 3 Studies 2021 ·Journal of Pain Research ·Michael Camilleri, M. Hale, Bart Morlion, Jan Tack, Lynn R. Webster, James Wild	6
6	The Physiology and Maintenance of Respiration: A Narrative Review 2020 ·SHILAP Revista de lepidopterología ·Lynn R. Webster, Suzanne Karan	23
7	A Longitudinal Study of the Association of Opioid Use with Change in Pain Interference and Functional Limitations in a Nationally Representative Cohort of Adults with Osteoarthritis in the United States 2019 ·Advances in Therapy ·Drishti Shah, Xiaohui Zhao, Wenhui Wei, Kavita Gandhi, Nilanjana Dwibedi, Lynn R. Webster, Usha Sambamoorthi	12
8	Long-term use of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: a randomized, double-blind, placebo-controlled phase 3 study 2018 ·Pain ·Lynn R. Webster, Srinivas Nalamachu, Bart Morlion, (unknown), (unknown), Tadaaki Yamada, Juan Camilo Arjona Ferreira	68
9	Efficacy of Lubiprostone for the Treatment of Opioid-Induced Constipation, Analyzed by Opioid Class 2017 ·Pain Medicine ·Lynn R. Webster, Randall P. Brewer, Peter Lichtlen, (unknown), Shadreck M. Mareya, (unknown)	13
10	Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid‐Induced Constipation 2017 ·Pain Practice ·Lynn R. Webster, Ulysses Diva, Raj Tummala, Mark Sostek	10
11	A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain 2016 ·Pain Medicine ·Lynn R. Webster, Tadaaki Yamada, Juan Camilo Arjona Ferreira	51
12	Pharmacogenetics and Personalized Medicine in Pain Management 2016 ·Clinics in Laboratory Medicine ·Lynn R. Webster, Inna Belfer	20
13	Correlation of Subjective Effects with Systemic Opioid Exposure from Fixed-Dose Combinations of Oxycodone/Acetaminophen in Recreational Users of Prescription Drugs 2015 ·Pain Medicine ·(unknown), Krishna Devarakonda, (unknown), (unknown), Thomas Barrett, Lynn R. Webster	8
14	A Randomized, Double-Blind, Double-Dummy Study to Evaluate the Intranasal Human Abuse Potential and Pharmacokinetics of a Novel Extended-Release Abuse-Deterrent Formulation of Oxycodone 2015 ·Pain Medicine ·Lynn R. Webster, Ernest A. Kopecky, Michael D. Smith, Alison B. Fleming	24
15	Biased agonism of the μ-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: A randomized, double-blind, placebo-controlled, crossover study in healthy volunteers 2014 ·Pain ·David G. Soergel, Ruth Ann Subach, Nancy Burnham, Michael W. Lark, Ian E. James, Brian M. Sadler, Franck Skobieranda, Jonathan D. Violin, Lynn R. Webster	220
16	Intrathecal Gabapentin to Treat Chronic Intractable Noncancer Pain 2013 ·Anesthesiology ·Richard Rauck, Robert J. Coffey, David M. Schultz, Mark S. Wallace, Lynn R. Webster, Sally McCarville, Eric Grigsby, Linda M. Page	33
17	Evaluation of the analgesic efficacy of AZD1940, a novel cannabinoid agonist, on post-operative pain after lower third molar surgical removal 2013 ·Scandinavian Journal of Pain ·Jarkko Kalliomäki, Märta Segerdahl, Lynn R. Webster, (unknown), Karin Huizar, Peter Annas, Rolf Karlsten, H. Quiding	49
18	Fentanyl Buccal Tablet Compared with Immediate-Release Oxycodone for the Management of Breakthrough Pain in Opioid-Tolerant Patients with Chronic Cancer and Noncancer Pain: A Randomized, Double-Blind, Crossover Study Followed by a 12-Week Open-Label Phase to Evaluate Patient Outcomes 2013 ·Pain Medicine ·Lynn R. Webster, (unknown), Arvind Narayana, Craig Q. Earl, Ronghua Yang	20
19	TD-1211 demonstrates a durable increase in bowel movement frequency and return toward normal bowel function in a 5-week Ph2b Opioid-Induced Constipation (OIC) study 2013 ·Journal of Pain ·R. Vickery, (unknown), Ullrich Schwertschlag, (unknown), Lynn R. Webster, D. M. Canafax	6
20	Tolerability of NGX-4010, a capsaicin 8% patch for peripheral neuropathic pain 2011 ·Journal of Pain Research ·John F. Peppin, (unknown), Lynn R. Webster, (unknown), Jeffrey Tobias, (unknown)	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact